ClinicalTrials.gg

Ascletis Pharma Inc. clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 46 studies whose lead sponsor is Ascletis Pharma Inc. or one of 3 companies grouped under it. 5 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 30, 2026.

Our grouping of 3 registry names, not the registry’s. See them and correct one ↓

Compare Ascletis Pharma with Novo Nordisk and Eli Lilly →

Pipeline: 3 programs

Each counted once: 3 with a study Ascletis Pharma Inc. leads registered in the last two years.

  • Phase 1
  • Phase 3

The 1 phase-3 program — sign in to see them, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Ascletis Pharma Inc.’s own registered studies; Ascletis Pharma Inc.’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs Ascletis Pharma Inc.’s studies test, most open studies first — 10 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Coming up

3 of Ascletis Pharma Inc.’s studies under way reach primary completion within a year. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. D
  3. J’27
  4. F
  5. M
  6. 1A
  7. M
  8. 2J
  9. J
  10. A
  11. S
  12. O
  13. N

Add all 3 to your calendar (.ics) → With an account.

All 46 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now511%
  • Under way, not recruiting24%
  • Completed3780%
  • Stopped early24%

Phase

  • Phase 128
  • Phase 213
  • Phase 37

Where

  • China22
  • United States17
  • Greece2
  • Poland2
  • Germany2
  • United Kingdom2

Over the years

  1. 15
  2. 16
  3. 17
  4. 18
  5. 19
  6. 20
  7. 21
  8. 1022
  9. 23
  10. 24
  11. 25
  12. 626

By the year each study started. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Ascletis Pharma Inc..

  • Ascletis Pharmaceuticals Co., Ltd.
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    25 studies →
  • Ascletis Pharma (China) Co., Limited
    Regional office
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    12 studies →
  • Gannex Pharma Co., Ltd.
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    9 studies →

Studies

Recruiting first, then most recently updated. Showing 46 of 46.